Aerska

Biotech & Life Sciences · Dublin, Ireland · Founded 2025

RNAi medicines for treating neurological brain diseases MoreLess

Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in London, UK.

Valuation $100–500M

Headcount <100

Total funding $50–100M

Unlock exact values

Company overview

Aerska company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2025
Headquarters: Dublin, Ireland
Employees: 24
Open positions: 1
Dealroom signal: 60.4

Website ↗LinkedIn ↗

sub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorMedical ResearchsectorMedical & HealthcaresectorRNAsectorBiotech and PharmasectorCell TherapysectorTechbio Drug Discoveryclient focusb2c

Valuation & funding

Aerska funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	May 2026	$10M	$195M	Global Health Investment Corporation	↗
SERIES AOther financing	Feb 2026	$39M	$156M	Iaso Ventures · EQT Life Sciences · Age1	↗
SEEDOther financing	Oct 2025	$20M	$79M	Norrsken VC · BACKED VC · Age1 · Speedinvest	↗

Showing 3 recorded eventsUnlock the complete deal history →

Growth signals

Aerska website traffic

Latest recorded traffic for Aerska is 1.3K monthly website visits, up 18.2% over the last three months.

Latest monthly visits1.3K 3-month web change+18.2%

Monthly website visits6 observations · Oct 2025–May 2026

Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Aerska compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MOMoleculeaiAI driven drug-discovery platform that uses deep learning and generative modeling to radically shorten the time and cost of discovering new therapeutic molecules	New Delhi, India	Acquired	9	—	—
GEGenicityDeveloping on-the-shelf therapies for solid and liquid tumors using allogenic T-cell receptor therapies	Galway, Ireland	Operational
RBReThink64 BionetworksIntercellular router system for large-molecule drug delivery	Fremont, United States	Operational
ABAptuCure BioDeveloping AptuBodies, unique revolutionary synthetic aptamer-based nanoparticles mimicking antibody activity	Rehovot, Israel	Operational
ABAvenue BiosciencesInnovative protein engineering solutions integrating biologics and machine learning for therapeutic advancements	Palo Alto, United States	Operational
OLOlden LabsInnovative solutions for optimizing Apache2 server configurations on Ubuntu systems	San Francisco, United States	Operational
SBStemX BioInnovative 3D microtissue models for drug discovery and regenerative medicine research	Leiden, Netherlands	Operational
PTPasskey TherapeuticsDiscovering new medicines by unlocking rational polypharmacology	Cambridge, United States	Operational

Showing 8 of the closest matchesCompare every metric →

Talent graph

Aerska's talent

Book a demo to see the people

Team profiled 4 named & role-tagged

Founders /100 quality score

Key operators 3 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Aerska's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 7 investors entered at this stage

BACKED VC

Age1

Norrsken VC

Speedinvest

BlueYard Capital

Ada

Saras

Series A 3 investors entered at this stage

EQT Life Sciences

Iaso Ventures

Global Health Investment Corporation

Global footprint

Where Aerska has talent and traffic

Workforce by country

5 countries with
team presence

🇬🇧 United Kingdom38.9%

🇮🇪 Ireland27.8%

🇺🇸 United States22.2%

🇩🇪 Germany5.6%

🇳🇱 Netherlands5.6%

5 countries shown

In the news

Latest news about Aerska

Recent press, funding announcements, and product moves mentioning Aerska — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Aerska

An AI-synthesized read of the highest-engagement posts about Aerska on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aerska’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.